IMMUNOLOGY

Associated diseases: C8 DEFICIENCY, TYPE I, IMMUNODEFICIENCY 15, IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME-2, ?FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4, IMMUNODEFICIENCY, COMMON VARIABLE, 4, IMMUNODEFICIENCY 27A, MYCOBACTERIOSIS, AR, EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME, HYPER-IGE RECURRENT INFECTION SYNDROME, MANNOSIDOSIS, ALPHA-, TYPES I AND II, MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC, SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY, MANNOSIDOSIS, BETA, IMMUNODEFICIENCY 31C, AUTOSOMAL DOMINANT, AICARDI-GOUTIERES SYNDROME 7, MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39, SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADA DEFICIENCY, ADENOSINE DEAMINASE DEFICIENCY, PARTIAL, BARTH SYNDROME, MYASTHENIC SYNDROME, CONGENITAL, 10, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA, SELECTIVE T-CELL DEFECT, AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE II, ?INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2, IMMUNODEFICIENCY, COMMON VARIABLE, 6, DIABETES MELLITUS, PERMANENT NEONATAL, DIABETES MELLITUS, PERMANENT NEONATAL, WITH NEUROLOGIC FEATURES, DIABETES, PERMANENT NEONATAL, TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE, IMMUNODEFICIENCY 38, HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME, COMPLEMENT FACTOR D DEFICIENCY, ?IMMUNODEFICIENCY 39, ATELEIOTIC DWARFISM, IMMUNODEFICIENCY 14, AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION SYNDROME, STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET, ACRODERMATITIS ENTEROPATHICA, ?TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE, {SARCOIDOSIS, SUSCEPTIBILITY TO, 1}, SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION, LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4, NEUTROPENIA, SEVERE CONGENITAL 1, AUTOSOMAL DOMINANT, CANDIDIASIS, FAMILIAL, 9, RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER, ?RAS-ASSOCIATED AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME TYPE IV, SOMATIC, NIEMANN-PICK DISEASE, TYPE A, IMMUNODEFICIENCY 24, {HASHIMOTO THYROIDITIS}, LYMPHEDEMA, HEREDITARY, III, NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT, SCID DUE TO ABSENT CLASS II HLA ANTIGENS, IMMUNODEFICIENCY DUE TO PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY, KENNY-CAFFEY SYNDROME, TYPE 1, SYSTEMIC LUPUS ERYTHEMATOSUS 16, NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS, CHRONIC GRANULOMATOUS DISEASE DUE TO DEFICIENCY OF NCF-1, {AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME}, AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IB, AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IA, ?INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1, IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4, IMMUNODEFICIENCY, PRIMARY, AUTOSOMAL RECESSIVE, IL21R-RELATED, MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE), DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM, IMMUNODEFICIENCY WITH HYPER IGM, TYPE 5, RUBINSTEIN-TAYBI SYNDROME, GRISCELLI SYNDROME, TYPE 3, IMMUNODEFICIENCY 43, IMMUNODEFICIENCY 36, SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES, IMMUNODEFICIENCY 19, IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY, IMMUNODEFICIENCY 35, HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1, B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY, OROTIC ACIDURIA, IMMUNODEFICIENCY 7, TCR-ALPHA/BETA DEFICIENT, MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE), VELOCARDIOFACIAL SYNDROME, MEVALONIC ACIDURIA, {SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO}, {LUPUS NEPHRITIS, SUSCEPTIBILITY TO}, {SYSTEMIC LUPUS ERYTHEMATOSUS SUSCEPTIBILITY TO}, {ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, 3, SUSCEPTIBILITY TO}, HELSMOORTEL-VAN DER AA SYNDROME, IMMUNODEFICIENCY, X-LINKED, WITH HYPER-IGM, {ASTHMA, ASPIRIN-INDUCED, SUSCEPTIBILITY TO}, ASTHMA AND NASAL POLYPS, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3, IMMUNODEFICIENCY 31A, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT, {DIABETES MELLITUS, KETOSIS-PRONE, SUSCEPTIBILITY TO}, KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, ?IMMUNODEFICIENCY, COMMON VARIABLE, 11, IMMUNODEFICIENCY, COMMON VARIABLE, 2, IMMUNODEFICIENCY 32A, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT, LEPRECHAUNISM, IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1, FOLATE MALABSORPTION, HEREDITARY, SPLENIC HYPOPLASIA, C3 DEFICIENCY, ?IMMUNODEFICIENCY 22, SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B-CELL/NATURAL KILLER-CELL POSITIVE, SEVERE COMBINED IMMUNODEFICIENCY, T-CELL NEGATIVE, B-CELL/NATURAL KILLER CELL-POSITIVE TYPE, CANDIDIASIS, FAMILIAL, 2, AUTOSOMAL RECESSIVE, AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME, ?IMMUNODEFICIENCY 16, TRANSCOBALAMIN II DEFICIENCY, {CHRONIC INFECTIONS, DUE TO MBL DEFICIENCY}, IMMUNODEFICIENCY, COMMON VARIABLE, 10, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM, C2 DEFICIENCY, EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36, CARTILAGE-HAIR HYPOPLASIA, IMMUNODEFICIENCY 40, DYSKERATOSIS CONGENITA, X-LINKED, IMMUNODEFICIENCY 44, MUCKLE-WELLS SYNDROME, FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3, FILS SYNDROME, ADAMS-OLIVER SYNDROME 3, [BLOOD GROUP, DUFFY SYSTEM], IMMUNODEFICIENCY 33, ?CANDIDIASIS, FAMILIAL, 5, AUTOSOMAL RECESSIVE, MEGALOBLASTIC ANEMIA-1, FINNISH TYPE, MEGALOBLASTIC ANEMIA-1, NORWEGIAN TYPE, RIDDLE SYNDROME, RHEUMATOID ARTHRITIS, DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2, IMMUNODEFICIENCY 31B, MYCOBACTERIAL AND VIRAL INFECTIONS, AUTOSOMAL RECESSIVE, {HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3}, KAPPA LIGHT CHAIN DEFICIENCY, ?CANDIDIASIS, FAMILIAL, 8, IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED, AICARDI-GOUTIERES SYNDROME 1, DOMINANT AND RECESSIVE, 3-METHYLGLUTACONIC ACIDURIA, TYPE VII, WITH CATARACTS, NEUROLOGIC INVOLVEMENT AND NEUTROPENIA, PERIODIC FEVER, MENSTRUAL CYCLE DEPENDENT, HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC, RESISTANT TO IMATINIB, HERMANSKY-PUDLAK SYNDROME 2, PROPERDIN DEFICIENCY, X-LINKED, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL, SEVERE COMBINED IMMUNODEFICIENCY, ATHABASCAN TYPE, IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN, T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY, {ATOPY, SUSCEPTIBILITY TO}, [IGE, ELEVATED LEVEL OF], ATOPY, {ATOPY, RESISTANCE TO}, [IGE LEVELS QTL], AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V, CHRONIC GRANULOMATOUS DISEASE, AUTOSOMAL, DUE TO DEFICIENCY OF CYBA, {ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, 4, SUSCEPTIBILITY TO}, MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1, C8 DEFICIENCY, TYPE II, NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V, {?HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 7}, ?AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIB, RETICULAR DYSGENESIS, {HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6}, NEUTROPENIA, SEVERE CONGENITAL 2, AUTOSOMAL DOMINANT, IMMUNODEFICIENCY 12, {PSORIASIS SUSCEPTIBILITY 1}, EPILEPTIC ENCEPHALOPATHY LENNOX-GASTAUT TYPE, ?IMMUNODEFICIENCY 25, POLYARTERITIS NODOSA, CHILDHOOD-ONSET, PROLIDASE DEFICIENCY, GRISCELLI SYNDROME, TYPE 1, AGAMMAGLOBULINEMIA 6, TRICHOHEPATOENTERIC SYNDROME 1, TIMOTHY SYNDROME, {HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5}, INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASUCLAR MALFORMATIONS, WISKOTT-ALDRICH SYNDROME, NIJMEGEN BREAKAGE SYNDROME, CHRONIC GRANULOMATOUS DISEASE, X-LINKED, GM1-GANGLIOSIDOSIS, TYPE I, ARTS SYNDROME, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC, DIAMOND-BLACKFAN ANEMIA 7, ATAXIA-TELANGIECTASIA, ?IMMUNODEFICIENCY 45, MYASTHENIC SYNDROME, CONGENITAL, 5, WHIM SYNDROME, INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS, MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS, OBESITY, MORBID, DUE TO LEPTIN DEFICIENCY, IMMUNODEFICIENCY 30, AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS, NETHERTON SYNDROME, IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 2, {HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4}, AGAMMAGLOBULINEMIA 2, SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE, COMBINED IMMUNODEFICIENCY, X-LINKED, MODERATE, GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME, BONE MARROW FAILURE SYNDROME 2, COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS, HEMOLYTIC ANEMIA DUE TO TRIOSEPHOSPHATE ISOMERASE DEFICIENCY, IMMUNODEFICIENCY 8, JOUBERT SYNDROME 10, SCID, AUTOSOMAL RECESSIVE, T-NEGATIVE/B-POSITIVE TYPE, DIGEORGE SYNDROME, ?JOUBERT SYNDROME 26, THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME, VICI SYNDROME, IMMUNODEFICIENCY, COMMON VARIABLE, 7, AGAMMAGLOBULINEMIA 1, AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III, POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY, LYMPHOPROLIFERATIVE SYNDROME 1, LEUKOCYTE ADHESION DEFICIENCY, TYPE III, SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED, TRICHOHEPATOENTERIC SYNDROME 2, ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1, BERGER DISEASE, IMMUNODEFICIENCY 10, IMMUNODEFICIENCY 27B, MYCOBACTERIOSIS, AD, INTRINSIC FACTOR DEFICIENCY, IMMUNODEFICIENCY 29, MYCOBACTERIOSIS, IMMUNODEFICIENCY 23, IMMUNODEFICIENCY, COMMON VARIABLE, 5, ?CHARGE SYNDROME, CHARGE SYNDROME, {LEPROSY, SUSCEPTIBILITY TO}, COMPLEMENT FACTOR H DEFICIENCY, MYELOPEROXIDASE DEFICIENCY, {DIABETES MELLITUS, TYPE 1, SUSCEPTIBILITY TO}, {DIABETES MELLITUS, INSULIN-DEPENDENT}, {DIABETES, TYPE 1, SUSCEPTIBILITY TO}, {DIABETES MELLITUS, TYPE I, SUSCEPTIBILITY TO}, OGDEN SYNDROME, {MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO}, IMMUNODEFICIENCY 34, MYCOBACTERIOSIS, X-LINKED, HYPERTHYROIDISM, NONAUTOIMMUNE, COMMON VARIABLE IMMUNODEFICIENCY 1, POIKILODERMA WITH NEUTROPENIA, ?AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE, NEUTROPENIA, SEVERE CONGENITAL 3, AUTOSOMAL RECESSIVE, CHRONIC GRANULOMATOUS DISEASE DUE TO DEFICIENCY OF NCF-2, LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1, HYPER-IGD SYNDROME, METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS, CHILBLAIN LUPUS, AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, IMMUNODEFICIENCY 11, C1R/C1S DEFICIENCY, COMBINED, ?IMMUNODEFICIENCY 13, HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4, IMMUNODEFICIENCY, COMMON VARIABLE, 13, HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE, ICHTHYOSIS WITH CONFETTI, DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5, DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 4, AGAMMAGLOBULINEMIA, X-LINKED 1, ASPARTYLGLUCOSAMINURIA, AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE, C1Q DEFICIENCY, ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER IGE, AGAMMAGLOBULINEMIA 4, BLOOM SYNDROME, HYALINE FIBROMATOSIS SYNDROME, IMMUNODEFICIENCY 42, HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1, LEUKOCYTE ADHESION DEFICIENCY, GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE III, PEELING SKIN SYNDROME 1, ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, DURSUN SYNDROME, NEUTROPENIA, SEVERE CONGENITAL 4, AUTOSOMAL RECESSIVE, BRANCHIOOCULOFACIAL SYNDROME, 3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME, THROMBOCYTOPENIA, X-LINKED, THROMBOCYTOPENIA, X-LINKED, INTERMITTENT, CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF, COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF, MENTAL RETARDATION, AUTOSOMAL DOMINANT 24, {HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2}, CILIARY DYSKINESIA, PRIMARY, 6, COMPLEMENT FACTOR I DEFICIENCY, GLUCOCORTICOID DEFICIENCY, DUE TO ACTH UNRESPONSIVENESS, ROUSSY-LEVY SYNDROME, ?IMMUNODEFICIENCY 37, NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE, {AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE}, SCHIMKE IMMUNOOSSEOUS DYSPLASIA, IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY, IMMUNODEFICIENCY 18, SCID VARIANT, IMMUNODEFICIENCY 18, IMMUNODEFICIENCY 32B, MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE, ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2, IMMUNODEFICIENCY 17, CD3 GAMMA DEFICIENT, AGAMMAGLOBULINEMIA 3, LYMPHOPROLIFERATIVE SYNDROME 2, IMMUNODEFICIENCY 21, OMENN SYNDROME, {LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO}, MYOTONIC DYSTROPHY 2, ROIFMAN SYNDROME, CD8 DEFICIENCY, FAMILIAL, AICARDI-GOUTIERES SYNDROME 4, SICKLE CELL ANEMIA, GRISCELLI SYNDROME, TYPE 2, MASP2 DEFICIENCY, IMMUNODEFICIENCY 28, MYCOBACTERIOSIS, SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION, MYASTHENIA, CONGENITAL, 12, WITH TUBULAR AGGREGATES, IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY, IMMUNODEFICIENCY 46, NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE, TENORIO SYNDROME, HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME, NEUTROPENIA, SEVERE CONGENITAL, X-LINKED, C4A DEFICIENCY, CHEDIAK-HIGASHI SYNDROME, IMMUNODEFICIENCY, COMMON VARIABLE, 12, IMMUNODEFICIENCY 20, HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY, IMMUNODEFICIENCY 26, WITH OR WITHOUT NEUROLOGIC ABNORMALITIES, IMMUNODEFICIENCY, COMMON VARIABLE, 3, AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME , TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA, AGAMMAGLOBULINEMIA AND ISOLATED HORMONE DEFICIENCY, IMMUNODEFICIENCY 9, {HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO}, {HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1}, {CELIAC DISEASE, SUSCEPTIBILITY TO}, SMITH-KINGSMORE SYNDROME, MCLEOD SYNDROME WITH OR WITHOUT CHRONIC GRANULOMATOUS DISEASE

Associated genes: CCBE1, ERCC6L2, C3AR1, TRNT1, CYBA, HBB, CD3D, NCF1, CASP10, CPT2, TPI1, ZBTB24, RAG1, FAS, FERMT3, IKBKG, GFI1, MS4A2, DEAF1, ACP5, IRF7, SLC35A1, GLB1, RAB27A, TNFRSF13C, MPO, MYO5A, CD19, AK2, TREX1, COLQ, DOCK2, LMNB2, FCGR3A, CTPS1, SLC35A2, G6PC3, POLE, CFD, MANBA, KIAA0556, MAN2B1, IL10, IL2RA, LRBA, IGHM, NCF4, PRF1, MASP2, PTRF, USB1, BLNK, MPV17, GATA2, NBN, MSMO1, COG6, MS4A1, TFRC, WAS, ERCC2, MBL2, UNG, HELLS, C1QC, FOXN1, NAA10, CD40, VIPAS39, UMPS, BAAT, RBCK1, DNASE1L3, IL2RG, DNMT3B, RBPJ, SERPING1, AICDA, AMN, IFIH1, CHD7, ITPR3, KRAS, NFKB2, HTR1A, ICOS, CFP, PTPRC, NKX2-5, PTPN22, PLA2G7, PSMB8, IFNAR2, CD79A, CD8A, CECR1, SEMA3E, RNU4ATAC, DCLRE1C, C2, TTC37, BUB1B, CIITA, SKIV2L, HLA-DRB1, CRIPT, THBD, CD3E, ANTXR2, LEP, SLC29A3, PIK3CD, XRCC4, RFXAP, GFPT1, NFKBIA, HAVCR1, NLRP3, COPA, ORAI1, HLA-DQA1, CARD9, CD247, PHF11, CD27, C4A, STAT1, VPS33B, C1R, MLPH, IRF8, IL17RC, GLIS3, PDGFRA, NCF2, SLC35C1, C3, CREBBP, CD81, FCGR2A, RMRP, TMEM173, TNFRSF4, NLRC4, TSHR, SH2D1A, FBXL4, STX11, SLC22A4, AGA, DKC1, CD79B, TYK2, SPATA5, INS, IFNGR1, PMM2, MALT1, XK, TBX1, TNFRSF13B, FCN3, STIM1, MPZ, KCNJ11, IL7R, CFHR3, NRAS, IGLL1, MCM4, ZAP70, OAS1, IRF5, PRPS1, SMPD1, SMAD9, CHAT, IL12RB1, INSR, MVK, MC2R, PADI4, DOK7, TAZ, PNP, GCK, TTC7A, CFH, SMARCAL1, FOXP3, SPINK5, EGFR, MTOR, ITGB2, C1QA, UNC119, NGF, TRAC, PRKDC, CYBB, CARD11, CFI, RBM8A, C1QB, ACKR1, HLA-C, PIEZO1, MPLKIP, TBX21, IGKC, IL17RA, RPSA, IKZF1, SCN1A, CDSN, DSG1, ISG15, CNBP, HAX1, HNF1A, ADNP, CUBN, RAG2, GH1, TFAP2A, PAX4, CFHR1, NME8, STAT2, BTK, LYST, STAT3, TLR2, BCL10, AIRE, LCK, DDX41, ELANE, CD244, SERAC1, IFNGR2, CORO1A, GIF, ITK, TTI2, CD40LG, PRKCD, B2M, PMP22, SLC46A1, CD46, IL4R, RNF168, PTGER2, JAGN1, DOCK8, RORC, NTRK1, TRAF3IP2, PEPD, ATM, JAK3, DNASE1, GJB2, IL12B, IRF3, NFKB1, EPG5, TBCE, CACNA1C, RFX5, NFKBIL1, RFXANK, CLPB, FADD, CFB, RANBP2, BLM, CXCR4, FCGR2B, RNASEH2A, PLCG2, SLC39A4, CD3G, IL21R, SP110, RPL11, TNFAIP3, OFD1, RTEL1, HLA-DQB1, LAMTOR2, PGM3, ADAM17, RNF113A, TCN2, CTLA4, ABCC8, FASLG, KRT10, AP3B1, RNF125, ADA, NHP2, VPS45, IKBKB, GTF2H5, C8A, SELP, CR2, CASP8, PIGR, C8B, ALG13, IL21, PIK3R1